Birgit Gaschler‐Markefski
Boehringer Ingelheim (Germany) · 43 works · 2,614 citations · h-index 20
Top works
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- A movement-sensitive area in auditory cortex
- Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
- Lateralized auditory spatial perception and the contralaterality of cortical processing as studied with functional magnetic resonance imaging and magnetoencephalography
- Lume-lung 2: A multicenter, randomized, double-blind, phase III study of nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after failure of first-line chemotherapy.
- Functional magnetic resonance imaging of a human auditory cortex area involved in foreground–background decomposition
- Electrodynamic headphones and woofers for application in magnetic resonance imaging scanners
- Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer
- The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy: Results from an Open-Label, Randomized Phase II Clinical Trial
- A statistical model for the dependence between progression‐free survival and overall survival
- Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
- Auditory stream segregation relying on timbre involves left auditory cortex
- An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.
- Statistical methods in functional magnetic resonance imaging with respect to nonstationary time‐series: Auditory cortex activity
- Embracing model-based designs for dose-finding trials
- Lateralized processing of speech prosodies in the temporal cortex: a 3-T functional magnetic resonance imaging study
- Activation of Human Auditory Cortex in Retrieval Experiments: An fMRI Study
- Randomized phase II trial of two dosing schedules of BI 2536, a novel Plk-1 inhibitor, in patients with relapsed advanced or metastatic non-small-cell lung cancer (NSCLC)
- Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial
- A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer